Erwan PENCREAC’H

MCUPH

ORCID – ResearcherID

(+33) 03 88 12 75 37

(+33) 03 88 27 53 64

 

 

 

Liste des publications :

 

Rimelen, V., Ahle, G., Pencreach, E., Zinniger, N., Debliquis, A., Zalmaï, L., … Drénou, B. (2019). Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis. Acta Neuropathologica Communications, 7(1), 43. https://doi.org/10.1186/s40478-019-0692-8
Davidson, G., Coassolo, S., Kieny, A., Ennen, M., Pencreach, E., Malouf, G. G., … Davidson, I. (2019). Dynamic Evolution of Clonal Composition and Neoantigen Landscape in Recurrent Metastatic Melanoma with a Rare Combination of Driver Mutations. The Journal of Investigative Dermatology, 139(8), 1769–1778. https://doi.org/10.1016/j.jid.2019.01.027
Mammadova-Bach, E., Rupp, T., Spenlé, C., Jivkov, I., Shankaranarayanan, P., Klein, A., … Lefebvre, O. (2018). Laminin α1 orchestrates VEGFA functions in the ecosystem of colorectal carcinoma. Biology of the Cell, 110(8), 178–195. https://doi.org/10.1111/boc.201800007
Emprou, C., Le Van Quyen, P., Jégu, J., Prim, N., Weingertner, N., Guérin, E., … Beau-Faller, M. (2018). SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients. Cancer Medicine, 7(7), 3278–3291. https://doi.org/10.1002/cam4.1545
Nguyen, A., Moussallieh, F. M., Mackay, A., Cicek, A. E., Coca, A., Chenard, M. P., … Entz-Werlé, N. (2017). Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1α axis inhibition. Oncotarget, 8(42), 71597–71617. https://doi.org/10.18632/oncotarget.16500
Romain, B., Benbrika-Nehmar, R., Marisa, L., Legrain, M., Lobstein, V., Oravecz, A., … Pencreach, E. (2017). Histone hypoacetylation contributes to CXCL12 downregulation in colon cancer: impact on tumor growth and cell migration. Oncotarget, 8(24), 38351–38366. https://doi.org/10.18632/oncotarget.16323
Hanns, E., Job, S., Coliat, P., Wasylyk, C., Ramolu, L., Pencreach, E., … Jung, A. C. (2015). Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature. Oral Oncology, 51(9), 848–856. https://doi.org/10.1016/j.oraloncology.2015.06.003
Romain, B., Hachet-Haas, M., Rohr, S., Brigand, C., Galzi, J.-L., Gaub, M.-P., … Guenot, D. (2014). Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer. Molecular Cancer, 13, 58. https://doi.org/10.1186/1476-4598-13-58
Derbal-Wolfrom, L., Pencreach, E., Saandi, T., Aprahamian, M., Martin, E., Greferath, R., … Freund, J.-N. (2013). Increasing the oxygen load by treatment with myo-inositol trispyrophosphate reduces growth of colon cancer and modulates the intestine homeobox gene Cdx2. Oncogene, 32(36), 4313–4318. https://doi.org/10.1038/onc.2012.445
Nedeva, I., Koripelly, G., Caballero, D., Chièze, L., Guichard, B., Romain, B., … Riveline, D. (2013). Synthetic polyamines promote rapid lamellipodial growth by regulating actin dynamics. Nature Communications, 4, 2165. https://doi.org/10.1038/ncomms3165
Marisa, L., de Reyniès, A., Duval, A., Selves, J., Gaub, M. P., Vescovo, L., … Boige, V. (2013). Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Medicine, 10(5), e1001453. https://doi.org/10.1371/journal.pmed.1001453
Nguyen, A., Lasthaus, C., Guerin, E., Marcellin, L., Pencreach, E., Gaub, M.-P., … Entz-Werle, N. (2013). Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse. Cancers, 5(2), 662–675. https://doi.org/10.3390/cancers5020662
Guérin, E., Raffelsberger, W., Pencreach, E., Maier, A., Neuville, A., Schneider, A., … Guenot, D. (2012). In vivo topoisomerase I inhibition attenuates the expression of hypoxia-inducible factor 1α target genes and decreases tumor angiogenesis. Molecular Medicine (Cambridge, Mass.), 18, 83–94. https://doi.org/10.2119/molmed.2011.00120
Pencreach, E., Guérin, E., Nicolet, C., Lelong-Rebel, I., Voegeli, A.-C., Oudet, P., … Guenot, D. (2009). Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 15(4), 1297–1307. https://doi.org/10.1158/1078-0432.CCR-08-0889
Weber, J.-C., Meyer, N., Pencreach, E., Schneider, A., Guérin, E., Neuville, A., … Gaub, M.-P. (2007). Allelotyping analyses of synchronous primary and metastasis CIN colon cancers identified different subtypes. International Journal of Cancer. Journal International Du Cancer, 120(3), 524–532. https://doi.org/10.1002/ijc.22343
Guenot, D., Guérin, E., Aguillon-Romain, S., Pencreach, E., Schneider, A., Neuville, A., … Gaub, M.-P. (2006). Primary tumour genetic alterations and intra-tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability. The Journal of Pathology, 208(5), 643–652. https://doi.org/10.1002/path.1936